Letters to the Editor
Version of Record online: 1 JUL 2013
Copyright © 2013 by the American College of Rheumatology
Arthritis Care & Research
Volume 65, Issue 7, page 1205, July 2013
How to Cite
Somers, T. J., Kurakula, P. C., Criscione-Schreiber, L., Keefe, F. J. and Clowse, M. E. B. (2013), Reply. Arthritis Care Res, 65: 1205. doi: 10.1002/acr.21960
- Issue online: 1 JUL 2013
- Version of Record online: 1 JUL 2013
- Accepted manuscript online: 31 JAN 2013 11:21AM EST
We read the comments by Navarrete-Navarrete et al regarding our article investigating how self-efficacy for pain control and pain catastrophizing are related to pain, stiffness, fatigue, and psychological distress in patients with SLE. Navarrete-Navarrete et al directed readers to their important study regarding the role of high levels of chronic stress experienced by SLE patients in relevant SLE outcomes () as well as an interesting intervention trial in SLE patients ().
Navarrete-Navarrete et al conducted a study suggesting that high levels of daily stress, although not stressful life events, were associated with an exacerbation of SLE symptoms (). Subsequently, the authors carried out a randomized controlled trial examining the efficacy of CBT for coping with chronic stress in patients with SLE (). In this trial, 45 patients with SLE and high levels of daily stress were randomized to either a group receiving 10 consecutive weekly sessions of CBT for coping with chronic stress or a control group. The authors examined posttreatment outcomes over the next year and found that participants in the CBT intervention group reported decreased levels of depression, anxiety, and daily stress compared to participants in the control group. Participants in the CBT stress coping intervention group also demonstrated significant improvements in QOL and somatic symptoms including pain compared to the control group. No differences between the groups were found for immunologic measures.
Our study specifically examined how the pain coping cognitions (i.e., self-efficacy for pain control and pain catastrophizing) of the SLE patients were related to physical symptoms and psychological distress in patients with SLE. We found that pain coping cognitions were related to pain, stiffness, fatigue, and mood even after controlling for age, race, and disease activity. In our article, we suggested that shifting the treatment of SLE patients from a traditional approach with medication (e.g., immunosuppressive therapy) to a multidisciplinary approach that includes treatments addressing pain cognitions may have an important and positive impact on SLE outcomes. The application of a tailored pain coping skills training (PCST) () protocol that aims to increase self-efficacy for pain control and decrease pain catastrophizing may be particularly beneficial for these patients.
A PCST protocol tailored for SLE patients would focus on enhancing the ability of these patients to manage their pain and decrease their negative pain coping strategies (i.e., pain catastrophizing). We hypothesize that such a PCST protocol would result in increased self-efficacy for pain control, decreased pain catastrophizing, decreased pain, and increased physical and psychological functioning. The CBT stress coping protocol that targeted decreases in daily stress that Navarrete-Navarrete et al tested produced significant reductions in pain, depression, anxiety, and daily stress as well as somatic symptoms.
It would be interesting to compare the efficacy of a tailored PCST protocol to the CBT-based chronic stress coping protocol proposed by Navarrete-Navarrete et al () in patients with SLE. Both protocols may be effective for treating certain physical symptoms and psychological distress, although the degree of improvement may vary; it remains unknown whether the CBT-based chronic stress coping protocol would impact important pain coping cognitions. Another important aim of future work would be to examine how pretreatment individual factors (e.g., age, disease severity, pain levels, and daily stressors) moderate the impact of such intervention protocols on important outcomes. For instance, SLE patients who have high levels of pain and/or pain catastrophizing but limited levels of daily stress may benefit most from a PCST protocol, while SLE patients with low levels of pain catastrophizing but high levels of daily stress may benefit from a CBT-based protocol focused on coping with chronic stress. In another instance, patients with moderate levels of both pain catastrophizing and daily stress may benefit from a combination of these intervention protocols.
We appreciate the interest by Navarrete-Navarrete et al in our work and their comments. We plan to move forward by examining CBT-based pain interventions in patients with SLE and will certainly use their findings to inform and advance our future work.